(American College of Rheumatology) In response to the Trump Administration's American Patients First drug pricing blueprint, the American College of Rheumatology — which represents more than 7,700 rheumatologists and rheumatology health professionals in the US 0- today issued a set of policy principles that rheumatology leaders urge federal officials to adopt as they consider drug policy changes affecting the health care of chronically ill Americans.